Interleukin 2 inhibits in vitro granulocyte-macrophage colony formation
- PMID: 2442258
Interleukin 2 inhibits in vitro granulocyte-macrophage colony formation
Abstract
We have previously shown that murine bone marrow cells cultured with interleukin 2 (IL-2) produce interferon-alpha/beta (MuIFN-alpha/beta) and that IFN-alpha/beta can suppress in vitro granulocyte-macrophage colony-forming cell formation (GM-CFC). In this study, IL-2 was directly assessed for its ability to inhibit in vitro granulocyte and/or macrophage colony-forming cell formation (GM-CFC/M-CFC). C57BL/6 bone marrow cells were cultured with different colony-stimulating factors (CSF), i.e., partially purified macrophage-CSF (M-CSF) or recombinant granulocyte and macrophage CSF (GM-CSF) in the presence or absence of different IL-2 preparations. Partially purified mouse IL-2 or recombinant human or mouse IL-2 (rHuIL-2 and rMuIL-2) totally inhibit GM-CFC and M-CFC formation at 7 days of culture. The level of inhibition mediated by IL-2 was concentration-dependent, with as little as 1 U/ml giving total inhibition of colony formation. The ability of IL-2 to inhibit colony formation was completely abolished by treatment with antisera to IL-2. MuIFN-alpha/beta and MuIFN-gamma appeared to play no role in IL-2-induced myelo-suppression in that addition of antisera to these IFN failed to block IL-2-induced suppression. Myelo-suppression mediated by IL-2 was independent of the concentration of CSF used in the bone marrow cultures. Suppression was also not dependent upon the initial presence of T cells or natural killer (NK) cells. Bone marrow cells depleted of Thy-1+, Lyt-1+, Lyt-2+, NK-1.1+, Asialo GM1+, or Qa-5+ cells were as susceptible to IL-2 induced suppression as untreated or complement-treated bone marrow cells. These results suggest that IL-2 may play an important role in regulating different aspects of hematopoiesis.
Similar articles
-
Synergistic effects of purified recombinant human and murine B cell growth factor-1/IL-4 on colony formation in vitro by hematopoietic progenitor cells. Multiple actions.J Immunol. 1988 Dec 1;141(11):3852-62. J Immunol. 1988. PMID: 3053902
-
Functional characterization of mouse granulocytes and macrophages produced in vitro from bone marrow progenitors stimulated with interleukin 3 (IL-3) or granulocyte-macrophage colony-stimulating factor (GM-CSF).Exp Hematol. 1992 Oct;20(9):1135-40. Exp Hematol. 1992. PMID: 1361455
-
In vivo and in vitro interaction between interleukin 6 and granulocyte colony-stimulating factor in the regulation of murine hematopoiesis.Exp Hematol. 1992 Aug;20(7):874-8. Exp Hematol. 1992. PMID: 1378408
-
Does stem cell self renewal and progenitor cell commitment operate through an effector-memory cell mechanism?Immunol Lett. 1986 Sep;13(3):107-19. doi: 10.1016/0165-2478(86)90042-8. Immunol Lett. 1986. PMID: 3091489 Review.
-
The granulocyte-macrophage colony-stimulating factors.Science. 1985 Jul 5;229(4708):16-22. doi: 10.1126/science.2990035. Science. 1985. PMID: 2990035 Review.
Cited by
-
Relationship between colony-stimulating activity and interferon production during infection.Immunology. 1990 Jun;70(2):191-6. Immunology. 1990. PMID: 2115498 Free PMC article.
-
Suppression of monocyte and neutrophil function by recombinant IL-2.Mediators Inflamm. 1993;2(1):59-65. doi: 10.1155/S0962935193000080. Mediators Inflamm. 1993. PMID: 18475504 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Other Literature Sources
Research Materials
Miscellaneous